 |
|
|
| |
Pharmacokinetics of Firsocostat, an Acetyl-CoA Carboxylase
(ACC) Inhibitor, and Cilofexor, a Selective Nonsteroidal
Farnesoid X Receptor (FXR) Agonist, in Participants with Severe Renal Impairment
|
| |
| |
AASLD 2021 Nov 12-15
Elijah J. Weber, Islam Younis, Cara Nelson, Dora Ding, Ann R. Qin, Ryan S. Huss, Robert P. Myers and Ahmed A. Othman
Gilead Sciences, Inc., Foster City, CA, USA
|
| |
|
|
|
|
|
